D. Anticoagulant & Antiviral Candidates

Two Anticoagulant & Antiviral Drug Candidates

May 19, 2020
Tirofiban-C22H36N2O5S[1]
Heparin- C26H42N2O37S5[2-5]


Note that the combination of Tirofiban with Heparin is a common practice for treatment of acute coronary syndrome. Major functions of Tirofiban are described in the following.

Tirofiban - An Antiviral Blood Thinner with Significant Potentials


May 15, 2020


The functions of Tirofiban related to antiviral activities are displayed in the following table. From the information available in the public domain, COVID-19 does not change fundamentally in terms of its weakness that fails to protect itself from attacks of the human immune system and effective drugs. As a result, its protective shield can be smashed by adding more powerful drugs upon the endogenous weapons.

         

Note


Only major targets and target zones are listed in the table.

The Intensity rank follows an ascending sequence: B→A→AA→AAA for quantifying the interactions between a drug molecule and a specific biochemical target

In a target zone of the human body, more complicated details than those in the table are involved in a biochemical process.



[1] ClinicalTrials.gov Identifier: NCT04368377. April 29, 2020.

[2] ClinicalTrials.gov Identifier: NCT04345848. April 15, 2020.

[3] ClinicalTrials.gov Identifier: NCT04362085. April24, 2020.

[4] ClinicalTrials.gov Identifier: NCT04367831. April29, 2020.

[5] ClinicalTrials.gov Identifier: NCT04373707. May 4, 2020.